21 – 30 of 110
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms
(
- Contribution to journal › Article
-
Mark
TGF-β-mediated epithelial–mesenchymal transition and tumor-promoting effects in CMT64 cells are reflected in the transcriptomic signature of human lung adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Factors influencing concordance of pd-l1 expression between biopsies and cytological specimens in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung
(
- Contribution to journal › Article
-
Mark
Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers
(
- Contribution to journal › Article
-
Mark
The prognostic impact of the tumour stroma fraction : A machine learning-based analysis in 16 human solid tumour types
(
- Contribution to journal › Article
-
Mark
Higher concordance of PD-L1 expression between biopsies and effusions in epithelioid than in nonepithelioid pleural mesothelioma
(
- Contribution to journal › Article
-
Mark
Integration of multiomic annotation data to prioritize and characterize inflammation and immune-related risk variants in squamous cell lung cancer
(
- Contribution to journal › Article
-
Mark
Evaluation of NTRK immunohistochemistry as a screening method for NTRK gene fusion detection in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Infiltration of NK and plasma cells is associated with a distinct immune subset in non-small cell lung cancer
(
- Contribution to journal › Article